Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 1997, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares on a Registration Statement on Form S-3, or a successor form.
Appears in 2 contracts
Samples: Stock and Warrant Purchase Agreement (Nastech Pharmaceutical Co Inc), Stock and Warrant Purchase Agreement (Nastech Pharmaceutical Co Inc)
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19971995, the Company has filed with the SEC Commission all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares on a Registration Statement on Form S-3, or a successor form.
Appears in 2 contracts
Samples: Stock and Warrant Purchase Agreement (Novavax Inc), Stock and Warrant Purchase Agreement (Novavax Inc)
Filing of Reports. Since the Company's Annual Report on Form 10-K KSB for the fiscal year ended December 31, 19972000, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares on a Registration Statement registration statement on Form S-3, or a any successor formform (the "Registration Statement").
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (American Medical Alert Corp)
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19971996, the Company has filed with the SEC Commission all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act Act, and the Company is eligible to register the offer and resale of the Shares and by the Warrant Shares Purchaser on a Registration Statement on Form S-3, S-3 or a successor form.
Appears in 1 contract
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19971995, the Company has filed with the SEC Commission all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19972002, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and by the Warrant Shares holders thereof on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Samples: Common Stock Purchase Agreement (Questcor Pharmaceuticals Inc)
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19972000, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares by the holders thereof on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (Questcor Pharmaceuticals Inc)
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19971996, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act Act, and the Company is presently eligible to register the offer and resale of the Shares and the Warrant Shares by Genentech on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19971996, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Filing of Reports. Since the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 19972002, the Company has filed with the SEC all reports and other material required to be filed by it therewith pursuant to Section 13, 14 or 15(d) of the Exchange Act and the Company is eligible to register the offer and resale of the Shares and the Warrant Shares by the holders thereof on a Registration Statement on Form S-3, or a successor form.
Appears in 1 contract
Samples: Stock and Warrant Purchase Agreement (Questcor Pharmaceuticals Inc)
